Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balances, at Beginning of period at Dec. 31, 2023	$ 253,895	$ 4	$ 559,176	$ 347	$ (305,632)
Balances, at Beginning of period (in shares) at Dec. 31, 2023		54,992,784
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense, including employee stock purchase plan expense	10,246		10,246
Issuance of shares under at-the-market offering, net of issuance costs	22,787		22,787
Issuance of shares under at-the-market offering		1,772,278
Issuance of shares under employee stock purchase plan	650		650
Issuance of shares under employee stock purchase plan (in shares)		70,701
Employee stock purchase plan expense	387		387
Exercise of stock options	1,015		1,015
Exercise of stock options (in shares)		317,989
Vesting of restricted stock awards (in shares)		92,659
Net unrealized (loss) gain on marketable securities	(465)			(465)
Net loss	(61,352)				(61,352)
Balances, at End of period at Jun. 30, 2024	227,163	$ 4	594,261	(118)	(366,984)
Balances, at End of period (in shares) at Jun. 30, 2024		57,246,411
Balances, at Beginning of period at Dec. 31, 2023	253,895	$ 4	559,176	347	(305,632)
Balances, at Beginning of period (in shares) at Dec. 31, 2023		54,992,784
Balances, at End of period at Dec. 31, 2024	408,964	$ 7	843,920	143	(435,106)
Balances, at End of period (in shares) at Dec. 31, 2024		74,312,608
Balances, at Beginning of period at Mar. 31, 2024	236,318	$ 4	572,926	(10)	(336,602)
Balances, at Beginning of period (in shares) at Mar. 31, 2024		55,867,863
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense, including employee stock purchase plan expense	5,542		5,542
Issuance of shares under at-the-market offering, net of issuance costs	14,886		14,886
Issuance of shares under at-the-market offering		1,225,952
Issuance of shares under employee stock purchase plan	650		650
Issuance of shares under employee stock purchase plan (in shares)		70,701
Employee stock purchase plan expense	182		182
Exercise of stock options	75		75
Exercise of stock options (in shares)		29,587
Vesting of restricted stock awards (in shares)		52,308
Net unrealized (loss) gain on marketable securities	(108)			(108)
Net loss	(30,382)				(30,382)
Balances, at End of period at Jun. 30, 2024	227,163	$ 4	594,261	(118)	(366,984)
Balances, at End of period (in shares) at Jun. 30, 2024		57,246,411
Balances, at Beginning of period at Dec. 31, 2024	408,964	$ 7	843,920	143	(435,106)
Balances, at Beginning of period (in shares) at Dec. 31, 2024		74,312,608
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense, including employee stock purchase plan expense			9,070
Issuance of shares under employee stock purchase plan	748		748
Issuance of shares under employee stock purchase plan (in shares)		206,609
Exercise of stock options	$ 470		470
Exercise of stock options (in shares)	178,669	178,669
Issuance cost associated with private equity placement	$ (14)		(14)
Exchange of common stock shares for pre-funded warrants (in shares)		(6,070,000)
Net unrealized (loss) gain on marketable securities	171			171
Net loss	(74,173)				(74,173)
Balances, at End of period at Jun. 30, 2025	345,236	$ 7	854,194	314	(509,279)
Balances, at End of period (in shares) at Jun. 30, 2025		68,627,886
Balances, at Beginning of period at Mar. 31, 2025	383,452	$ 7	848,520	420	(465,495)
Balances, at Beginning of period (in shares) at Mar. 31, 2025		68,333,065
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense, including employee stock purchase plan expense	4,692		4,692
Issuance of shares under employee stock purchase plan	748		748
Issuance of shares under employee stock purchase plan (in shares)		206,609
Exercise of stock options	234		234
Exercise of stock options (in shares)		88,212
Net unrealized (loss) gain on marketable securities	(106)			(106)
Net loss	(43,784)				(43,784)
Balances, at End of period at Jun. 30, 2025	$ 345,236	$ 7	$ 854,194	$ 314	$ (509,279)
Balances, at End of period (in shares) at Jun. 30, 2025		68,627,886